Company news
Trivarx Limited (ASX:TRI) news
Trivarx Limited news releases on 6ix. Latest, Sep 26, 2019: Medibio Announces Results of Review of Partly Paid Shares
Press releases — page 3
Medibio Announces Results of Review of Partly Paid Shares
September 26, 2019
Fourth Pilot Agreement Signed with Compass Group for ilumen
August 30, 2019
Board Changes and Establishment of Advisory Board
August 29, 2019
MEB Signs Compass Group Australia to ilumen
July 29, 2019
MEB Partners with Corporate Wellness Solution Leader WellteQ
July 28, 2019
MEB Signs Second Compass Group PLC Pilot for ilumen
July 19, 2019
MEB Raises $4.02m via Placement and Fully Underwritten SPP
July 9, 2019
Suspension from Official Quotation
July 8, 2019
MEB Signs Compass Group to ilumen
June 30, 2019
Response to Appendix 4C Query
May 20, 2019
Regulatory and Commercialisation Strategy Update
April 29, 2019
Sponsored Research Agreement with Humanitas University
April 16, 2019
MEB Outsources Psychology Services in support of ilumen
March 13, 2019
Entitlement Issue Results and Shortfall Notification
March 12, 2019
Ilumen Successfully Completes First Commercial Program
March 6, 2019
Converting Note & Non-Renounceable Entitlement Offer
December 9, 2018
Exclusive Agreement Signed for ilumen Pilot Program
November 26, 2018
Response to ASX Appendix 4C Query
November 14, 2018
Medibio Provides Update on FDA Process
November 8, 2018
Medibio Appoints CEO and Managing Director
November 1, 2018
MEB Signs ilumen Contract with Large Australian Employer
October 23, 2018
Receipt of R&D Tax Incentive Refund
October 14, 2018
Medibio Releases Corporate Health Product, ilumen
October 3, 2018
Notice Received Under Section 249D of the Corporations Act
October 1, 2018
Executive Leadership Changes
September 20, 2018
Clinical Study Shows Improvement to Diagnostic Standard
September 5, 2018
Preliminary Final Report
August 29, 2018
Departure of Managing Director & Chief Executive Officer
August 28, 2018
Medibio Submits FDA De Novo Application
July 15, 2018
Medibio Receives TGA Approval
June 19, 2018
MEB Signs Global Contract with Jacobs Engineering
May 25, 2018
Medibio Announces Next Tranche of Corporate Health Contracts
May 9, 2018
Medibio Signs First Corporate Health Contract
May 8, 2018
Medibio Receives CE Certification
May 2, 2018
MEB signs binding term sheet to acquire Vital Conversations
March 4, 2018
Medibio Quarterly Update and Cash Flow Report
January 30, 2018
Agreement with Striiv to Accelerate Commercialisation
January 21, 2018
Medibio Announces ISO 13485 Certification
January 10, 2018
Medibio & Mayo Clinic collaborate on depression technology
December 13, 2017
Appendix 4C - quarterly
October 30, 2017
MEB completes heavily oversubscribed institutional placement
October 12, 2017
Response to ASX Query
October 10, 2017
Medibio enters into an Agreement with Otsuka Pharmaceutical
October 8, 2017
Medibio enters agreement with Mayo Clinc
October 3, 2017
Medibio initiates confirmatory study
August 21, 2017
Medibio announces positive clinical study results
August 2, 2017
Quarterly ASX Update and Cashflows
July 27, 2017
Scientific breakthrough on objective diagnosis of PTSD
June 26, 2017
Independent researchers present first data validating MEB
June 8, 2017
Signed second agreement for Wellness
May 17, 2017